News Updates
More Articles
- The Pitfalls and Promise of Cell and Gene Therapy Development: A Time for Concerted Action
- “Not Just Checking a Box”: A Call to Rethink Patient Involvement in the EU
- From Cells to Animals and Back Again: The Shifting Landscape of Cancer Efficacy and Safety Models
- Addressing Inequity: Embedding Inclusion and Diversity in UK Clinical Trials
- The Next AI Revolution: Computer System Validation
Addressing Inequity: Embedding Inclusion and Diversity in UK Clinical Trials
This article explores current clinical trial representation and inclusion initiatives led by the Health Research Authority (HRA) and Medicines & Healthcare products Regulatory Agency (MHRA) in the UK.